Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-03-01 16:29:59
Reporting Period:
Accepted Time:
2021-03-01 16:29:59
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222679 E Michael Prevoznik 500 Plaza Drive
Secaucus NJ 07094
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-25 801 $115.49 40,152 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,220 Indirect 401(k)/SDCP
  1. The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020.
  2. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.